Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
In vitro modeling of central nervous system myelination and remyelination.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Multiple sclerosis and breast cancer.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Epstein-Barr virus: an important vaccine target for cancer prevention.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.
Tysabri prescribing information
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Autoimmune myelopathies.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Pages
« first
‹ previous
…
144
145
146
147
148
149
150
151
152
…
next ›
last »